Romark Laboratories
Organization
Trials
Phase 3, Withdrawn, 0 people, Dec 14, 2021
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Phase 2/3, Completed, 624 people, Oct 25, 2010
Phase 2, Completed, 40 people, Oct 1, 2008
Phase 2, Completed, 112 people, Mar 18, 2008
Phase 2, Completed, 64 people, Jul 3, 2007
Phase 2/3, Completed, 121 people, Jan 12, 2007
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
Phase 2, Completed, 114 people, Jan 4, 2007
Phase 3, Terminated, 50 people, Oct 6, 2006
Sources: clinicaltrials.gov